The clinical impact of pharmacist interventions in an emergency unit
To evaluate the clinical impact, quantity and quality of pharmacist interventions in potential patients’ outcomes in a high risk area, in this case an emergency assessment unit. These interventions were related to identifying, preventing and resolving drug related problems.
A pharmaceutical care plan form was issued for every patient entering the study, where the investigator pharmacist would record any possible drug-related issue and the way a solution had been attempted. Each drug-related issue was blinded and assessed by two experienced healthcare professionals according to its potential to cause medical harm using the trust categorisation matrix.
Subjects and setting
190 patients admitted to the emergency assessment unit at New Cross hospital, a 700-bed general hospital in Wolverhampton, West Midlands, over a period of four months.
Main outcome measures
The assessment of drug-related issues by two healthcare professionals using the trust categorisation matrix.
The pharmacist intervened in 159 of a total of 190 patients (83.7%) giving rise to a total of 360 interventions with the mean number of interventions being 1.9 per patient. According to the external pharmacist, there were 134 red alerts before intervention by the pharmacist of which 126 (94%) were converted into green after intervention by the pharmacist. According to the assessor doctor there were 54 red alerts before intervention by the clinical pharmacist and all of them were converted to green after intervention by the pharmacist.
Pharmacist interventions were common and most of them related to preventable prescribing errors. The intervention of the clinical pharmacist significantly improved the predicted patient outcome by reducing the risk of harm in most cases.
Citation: The Salvadore DOI: 10.1211/PJ.2013.11124785
Recommended from Pharmaceutical Press
All you need to know about prescribing or administering drugs via enteral feeding tubes. Over 400 drug monographs as well as facts to inform clinical decision making.£54.00
Now in its eleventh edition, Stockley’s Drug Interactions is still the most comprehensive and authoritative international source of drug interaction information.£212.00
Disease Management covers the diseases commonly encountered in primary care by system, with common therapeutic issues. Includes case studies and self-assessment sections.£54.00
This established textbook covers every aspect of drug properties from the design of dosage forms to their delivery by all routes to sites of action in the body.£48.00
Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.£40.00